2024 AMCP Nexus Posters

As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus event.
Click on the poster image to view the full-size version.

Save: Making medications more affordable

Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care Setting

The recipient of a gold award, this study analyzed the impact of immunoglobulin dose optimization programs in a managed care setting. 

Impact of a Pharmacist-Facing Clinical Management Tool: Identification and Management of Cumulative Oversupply in Pharmacy Benefit Dupilumab Utilizers

This study analyzed managed care pharmacist outreach through Prime’s HighTouchRx® product to reduce drug therapy cost of the inflammation drug dupilumab (Dupixent®).

Dosage Form and Product Strength Optimization: Containing the Cost of Ibrutinib Therapy Through a Pharmacist-Facing Clinical Management Tool 

This study evaluated the effectiveness of Prime’s HighTouchRx product for improving cost containment associated of ibrutinib (Imbruvica®) for oral oncology therapy.

Real-World Extended Dosing Assessment for Eye(s) New to Faricimab-svoa Therapy

This study assessed extended dosing of faricimab-svoa (Vabysmo®) therapy for retinal diseases.

Simplify: Delivering an easy, transparent experience

Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators

The purpose of the study was to create a methodological framework for using propensity score weighting to adjust for varying risk profiles when comparing an index group to a benchmark group with a similar risk profile on pharmacy key performance indicators.

Promoting Health Equity Through Enhanced, Personalized Digital Outreach

This study analyzed engagement and Medicare health plan performance among Spanish-speaking populations.

Support: Helping people achieve better health

Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists at Two Years among Non-Diabetic Obese Commercially Insured Adults

The recipient of a silver award, this study is part of Prime Therapeutics’ ongoing real-world study of individuals who newly started GLP-1 drugs for weight loss.

Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated with Onasemnogene Abeparvovec (Zolgensma)

The recipient of a silver award, this study researched real-world spinal muscular atrophy Zolgensma® gene therapy treatment outcomes.

Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A Latent Profile Analysis

This study looked at patterns in ZIP codes across the United States and SDOH measures to identify medication adherence for patients with diabetes. 

Unlocking Public Health Insights: Leveraging Air Quality Data to Develop Social Determinants of Health Metrics Linked to Asthma Medication Ratio

This study explored how researchers can use SDOH measures to evaluate the treatment of asthma among affected populations.

Login Portals
Compliance / Legal
Careers
© 2025 Prime Therapeutics LLC